Distribution of influenza vaccine to high-risk groups

被引:51
|
作者
Ompad, Danielle C.
Galea, Sandro
Vlahov, David
机构
[1] NYU, Med Acad, Ctr Urban Epidemiol Studies, New York, NY 10029 USA
[2] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA
关键词
adult; aged; child; immunization; influenza; human; review; vaccination;
D O I
10.1093/epirev/mxj004
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Vaccine distribution programs have historically targeted individuals at high risk of complications due to influenza. Despite recommendations from the Advisory Committee on Immunization Practices, vaccination coverage among high-risk populations has been generally low. This review systematically summarizes the recent literature evaluating programs in different settings, from within medical settings to venue-based and community-based approaches, in an effort to identify successful program components. The published literature was identified by using the MEDLINE database from 1990 to 2006 covering studies that reported on interventions or programs aimed at vaccinating high-risk populations. The authors reviewed 56 studies. In the United States, the Healthy People 2010 goals included 90% vaccination coverage for adults aged >= 65 years and 60% for high-risk adults aged 18-64 years. Only a handful of the studies reviewed managed to meet those goals. Interventions that increased vaccination coverage to Healthy People 2010 goals included advertising, provider and patient mailings, registry-based telephone calls, patient and staff education, standing orders coupled with standardized forms, targeting of syringe exchange customers, and visiting nurses. Few studies evaluated the impact of vaccination programs by race/ethnicity and socioeconomic status. Few studies targeted individuals outside of the health-care and social services sectors. Given the growing disparities in health and health-care access, understanding the way in which interventions can remedy disparities is crucial.
引用
下载
收藏
页码:54 / 70
页数:17
相关论文
共 50 条
  • [1] Strategy for distribution of influenza vaccine to high-risk groups and children
    Longini, IM
    Halloran, ME
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2005, 161 (04) : 303 - 306
  • [2] High-risk Groups for Influenza Complications
    Uyeki, Timothy M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020,
  • [3] Optimizing the Live Attenuated Influenza A Vaccine Backbone for High-Risk Patient Groups
    Bonifacio, Joao P. P. L.
    Williams, Nathalia
    Garnier, Laure
    Hugues, Stephanie
    Schmolke, Mirco
    Mazel-Sanchez, Beryl
    JOURNAL OF VIROLOGY, 2022, 96 (20)
  • [4] Influenza Vaccine for Patients With High-risk Cardiovascular Disease
    Patel, Manish M.
    Uyeki, Timothy M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (01): : 33 - 35
  • [5] USE OF HIGHLY PURIFIED SUBVIRION TRIVALENT INFLUENZA VACCINE (GRIPPOVAC) IN GROUPS OF HIGH-RISK OF COMPLICATIONS
    CHUMAKOV, MP
    BEREGOVSKY, NA
    LINEV, MB
    REIZIN, FN
    MALYSHKINA, LP
    MATROSOVICH, MN
    MARTIYANOVA, LI
    PYATNITSKAYA, AF
    SOLOVYEVA, MV
    ZHURNAL MIKROBIOLOGII EPIDEMIOLOGII I IMMUNOBIOLOGII, 1992, (03): : 55 - 57
  • [6] Influenza vaccine uptake in Tunisia from two high-risk groups' perception and attitudes: a qualitative study
    Boukthir, Aicha
    Bouguerra, Hind
    Ben Salah, Afif
    Erber, Astrid C.
    Chaabene, Sana
    Moussa, Hayet
    Guillemette, Francois
    Ben Alaya, Nissaf
    Bettaieb, Jihene
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [7] Influenza vaccine uptake in Tunisia from two high-risk groups' perception and attitudes: A qualitative study
    Boukthir, Aicha
    Bouguerra, Hind
    Ben Salah, Afif
    Erber, Astrid
    Chaabene, Sana
    Moussa, Hayet
    Guillemette, Francois
    Ben Alaya, Nissaf
    Bettaieb, Jihene
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2023, 28 (SUPP1) : 389 - 389
  • [8] Beliefs and attitudes towards the influenza vaccine in high-risk individuals
    Santos, A. J.
    Kislaya, I.
    Machado, A.
    Nunes, B.
    EPIDEMIOLOGY AND INFECTION, 2017, 145 (09): : 1786 - 1796
  • [9] TRIAL OF BIVALENT INFLUENZA-A VACCINE IN HIGH-RISK INFANTS
    HALL, CB
    LEE, H
    ALEXSON, C
    MEAGHER, MP
    MANNING, JA
    JOURNAL OF INFECTIOUS DISEASES, 1977, 136 : S648 - S651
  • [10] COMPARISON OF LIVE AND INACTIVATED INFLUENZA VACCINE IN HIGH-RISK CHILDREN
    KING, JC
    GROSS, PA
    DENNING, CR
    GAERLAN, PF
    WRIGHT, PF
    QUINNAN, GV
    VACCINE, 1987, 5 (03) : 234 - 238